Document is current

Article History

Received: 15 June 2022

Accepted: 15 December 2022

First Online: 20 December 2022

Declarations

:

: The study protocol was approved by the ethics review committee of Kenyatta National Hospital and University of Nairobi (KNH-UON ERC; Ethical approval number P137/03/2015). Written informed consent was obtained for each volunteer before enrolment. All those diagnosed with HIV were referred to their primary SWOP clinics or to other local HIV care and treatment facilities for care and treatment.As part of the consenting process, all volunteers were told they would receive a licensed hepatitis B vaccine during the study, rather than a HIV vaccine candidate. An assessment of understanding was conducted prior to the volunteers signing the consent form to ensure that they understood the study design as well as knew the vaccine they were receiving. This assessment of understanding was repeated at the 6-month study visit.Volunteers with confirmed hepatitis B infection were referred to the liver clinic at Kenyatta National Hospital for treatment and care. Those who had a high CAGE score were referred to Noset rehabilitation clinic. Volunteers were reimbursed Ksh 800 (approx. 8US dollars) for their time and effort at each scheduled visit.

: Not applicable.

: The Authors declare that they have no competing interests.